Task Force Has Initiated Chronic Kidney Disease Review
New experts have joined the group currently evaluating whether to recommend routine screening for millions of U.S. adults.
Updated on Sept. 28, 2026 in Diabetes
Live Poll
Do you believe universal screening for chronic kidney disease should be standard for all adults?
The U.S. Preventive Services Task Force (USPSTF) is moving forward with an evidence review to determine guidelines for screening chronic kidney disease. This effort is critical for the estimated 37 million Americans living with the condition, 87% of whom remain undiagnosed.
Why it matters
Earlier identification of kidney issues allows for proactive treatment to manage metabolic and cardiovascular risks. Addressing these gaps is especially vital for marginalized groups, as Black, Hispanic, and Native American populations face significantly higher rates of kidney failure.
A study of 513,165 adults with type 2 diabetes highlights a disparity in diagnostic screening, showing nearly 90% received blood-based eGFR testing while only 53% underwent urine-based uACR analysis. The USPSTF is currently synthesizing data to shape future screening recommendations.
The players
U.S. Preventive Services Task Force (USPSTF)
An independent panel of national experts in disease prevention and evidence-based medicine that determines clinical guidelines for primary care.
U.S. Department of Health and Human Services (HHS)
The federal agency tasked with protecting the health of all Americans through oversight of public health programs and medical research appointments.
The details
Kidney health is determined by measuring estimated glomerular filtration rate (eGFR) via blood work and urine albumin-to-creatinine ratio (uACR) via urine tests. A formal diagnosis requires evidence of structural or functional abnormalities that persist for longer than three months. By refining screening protocols, experts aim to capture these markers before the disease progresses to irreversible damage.
Timeline
July 2023: The USPSTF published a final research plan for CKD screening.
September 17, 2026: HHS appointed eight new members to the USPSTF.
September 28, 2026: The current status of the evidence review was reported.
Health Landscape
The USPSTF Chronic Kidney Disease screening evidence review represents an ongoing effort to standardize early detection methods. It builds on the historical arc of treating kidney disease as a late-stage concern by shifting focus toward earlier intervention for asymptomatic populations.
Since routine screening is still being evaluated, it is worth discussing your individual risk factors for kidney disease with your doctor during your next physical. Be aware that patients with existing conditions like type 2 diabetes require consistent monitoring of both eGFR and uACR levels.
The takeaway
Chronic kidney disease often progresses silently, making awareness of your own testing status an important component of your health plan. Ask your physician if your current lab work already includes both eGFR and uACR tests to ensure a complete picture of your kidney function.
Further reading
Learn more about managing metabolic health and diagnostic standards in Diabetes.
Source note: This article includes information reported by Hcplive.
Live Poll
Do you believe universal screening for chronic kidney disease should be standard for all adults?
